![Thomas Hofmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Hofmann
Amministratore Delegato presso Aumapharma, Inc.
Profilo
Thomas Hofmann is the founder of Aumapharma, Inc., QrumPharma, Inc. He previously worked as a Principal at Windtree Therapeutics, Inc. and Corus Pharma, Inc. He also served as the Chief Medical Officer & Head-Clinical Development at Vectura GmbH from 2013 to 2014.
Additionally, he held a Principal position at Pulmopharm GmbH.
Dr. Hofmann's education includes a doctorate degree from the University of Giessen, which was conferred in 1994.
Posizioni attive di Thomas Hofmann
Società | Posizione | Inizio |
---|---|---|
Aumapharma, Inc. | Amministratore Delegato | - |
QrumPharma, Inc.
![]() QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Amministratore Delegato | - |
Precedenti posizioni note di Thomas Hofmann
Società | Posizione | Fine |
---|---|---|
MANNKIND CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2024 |
Vectura GmbH
![]() Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Direttore Tecnico/Scientifico/R&S | 01/07/2014 |
WINDTREE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Pulmopharm GmbH | Corporate Officer/Principal | - |
Corus Pharma, Inc.
![]() Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Thomas Hofmann
University of Giessen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
WINDTREE THERAPEUTICS, INC. | Health Technology |
MANNKIND CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
Corus Pharma, Inc.
![]() Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
Pulmopharm GmbH | |
Aumapharma, Inc. | |
QrumPharma, Inc.
![]() QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
Vectura GmbH
![]() Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
- Borsa valori
- Insiders
- Thomas Hofmann